Published in Diabetes Care on February 01, 2005
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
The metabolic syndrome. Endocr Rev (2008) 5.33
Metabolic syndrome: definitions and controversies. BMC Med (2011) 3.80
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetes Care (2008) 2.73
Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke (2007) 2.55
Insulin resistance and atherosclerosis. J Clin Invest (2006) 2.27
Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension. Am J Respir Crit Care Med (2010) 1.85
Effects of etanercept in patients with the metabolic syndrome. Arch Intern Med (2006) 1.82
Distinct component profiles and high risk among African Americans with metabolic syndrome: the Jackson Heart Study. Diabetes Care (2008) 1.56
Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project. PLoS One (2014) 1.54
Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc Diabetol (2009) 1.53
Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis (2007) 1.50
Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia (2006) 1.48
Diet soft drink consumption is associated with an increased risk of vascular events in the Northern Manhattan Study. J Gen Intern Med (2012) 1.37
Prevalence of metabolic syndrome in the Canadian adult population. CMAJ (2011) 1.32
Prevalence of metabolic syndrome associated with body burden levels of dioxin and related compounds among Japan's general population. Environ Health Perspect (2008) 1.28
Individual and neighborhood socioeconomic status characteristics and prevalence of metabolic syndrome: the Atherosclerosis Risk in Communities (ARIC) Study. Psychosom Med (2008) 1.27
The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr (2009) 1.25
Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS). Am Heart J (2008) 1.22
Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med (2007) 1.21
Life course socioeconomic conditions and metabolic syndrome in adults: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol (2009) 1.17
Identifying risk factors for metabolic syndrome in biomedical text. AMIA Annu Symp Proc (2007) 1.16
Association between physical activity and metabolic syndrome in middle-aged Japanese: a cross-sectional study. BMC Public Health (2011) 1.15
Paleolithic nutrition for metabolic syndrome: systematic review and meta-analysis. Am J Clin Nutr (2015) 1.12
Sickness absence as a prognostic marker for common chronic conditions: analysis of mortality in the GAZEL study. Occup Environ Med (2008) 1.08
Abnormal cardiac structure and function in the metabolic syndrome: a population-based study. Mayo Clin Proc (2008) 1.07
The metabolic syndrome and behavioral correlates in obese patients with binge eating disorder. Obesity (Silver Spring) (2008) 1.07
The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study. Ann Epidemiol (2007) 1.06
Severity of the metabolic syndrome as a predictor of type 2 diabetes between childhood and adulthood: the Princeton Lipid Research Cohort Study. Diabetologia (2015) 1.06
Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study. Int J Obes (Lond) (2008) 1.05
Fatty liver, carotid disease and gallstones: a study of age-related associations. World J Gastroenterol (2006) 1.03
High-sensitivity C-reactive protein and gamma-glutamyl transferase levels are synergistically associated with metabolic syndrome in community-dwelling persons. Cardiovasc Diabetol (2010) 1.02
Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities--cross-sectional study of the general population. BMC Cardiovasc Disord (2007) 1.02
Plasma lipid concentrations in nondiabetic African American adults: associations with insulin resistance and the metabolic syndrome. Metabolism (2007) 1.01
Prevalence of metabolic syndrome in bus and truck drivers in Kashan, Iran. Diabetol Metab Syndr (2011) 1.01
Mineralocorticoid receptor antagonists and the metabolic syndrome. Curr Hypertens Rep (2010) 1.01
Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications. Arthritis Res Ther (2008) 1.01
Sociodemographic disparities in the composition of metabolic syndrome components among adults in South Korea. Diabetes Care (2012) 1.01
Impact of metabolic syndrome and its individual components on the presence and severity of angiographic coronary artery disease. Yonsei Med J (2010) 1.00
Metabolic syndrome increases the risk of stroke: a 5-year follow-up study in a Chinese population. J Neurol (2009) 1.00
Obesity and obesity related co-morbidities in a referral population of children with asthma. Pediatr Pulmonol (2009) 0.99
Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study. Eur J Epidemiol (2010) 0.99
Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes. Antioxid Redox Signal (2011) 0.97
Neighborhood disadvantage, neighborhood safety and cardiometabolic risk factors in African Americans: biosocial associations in the Jackson Heart study. PLoS One (2013) 0.97
Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study. Exp Mol Med (2013) 0.95
Metabolic syndrome and 16-year cognitive decline in community-dwelling older adults. Ann Epidemiol (2012) 0.94
Metabolic syndrome in central Brazil: prevalence and correlates in the adult population. Diabetol Metab Syndr (2012) 0.94
Dietary patterns of Korean adults and the prevalence of metabolic syndrome: a cross-sectional study. PLoS One (2014) 0.93
Metabolic syndrome is associated with change in subclinical arterial stiffness: a community-based Taichung community health study. BMC Public Health (2011) 0.91
Insulin-like growth factor-1 deficiency and metabolic syndrome. J Transl Med (2016) 0.90
Association of metabolic syndrome and insulin resistance with congestive heart failure: findings from the Third National Health and Nutrition Examination Survey. J Epidemiol Community Health (2007) 0.90
The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study. Atherosclerosis (2015) 0.89
The effects of old, new and emerging medicines on metabolic aberrations in PCOS. Ther Adv Endocrinol Metab (2012) 0.89
Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention. BMC Public Health (2009) 0.88
Lipid profile components and subclinical cerebrovascular disease in the northern Manhattan study. Cerebrovasc Dis (2014) 0.88
Association between diabetes mellitus with metabolic syndrome and diabetic microangiopathy. Exp Ther Med (2014) 0.88
Metabolic syndrome and physical performance in elderly men: the osteoporotic fractures in men study. J Am Geriatr Soc (2011) 0.88
The metabolic syndrome and cognitive decline in the Atherosclerosis Risk in Communities study (ARIC). Dement Geriatr Cogn Disord (2014) 0.88
A gender-stratified comparative analysis of various definitions of metabolic syndrome and cardiovascular risk in a multiethnic U.S. population. Metab Syndr Relat Disord (2011) 0.87
Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR. Nutrients (2010) 0.87
Metabolic syndrome and new onset diabetes after transplantation in kidney transplant recipients. Clin Transplant (2010) 0.87
Relationship between achieved blood pressure, dietary habits and cardiovascular disease in hypertensive patients treated with olmesartan: the OMEGA study. Hypertens Res (2012) 0.87
Prevalence of metabolic syndrome in adult population from zahedan, southeast iran. Iran J Public Health (2012) 0.87
Adiponectin: an adipokine with protective features against metabolic syndrome. Iran J Basic Med Sci (2015) 0.87
Metabolic syndrome as a cardiovascular disease risk factor: patients evaluated in primary care. BMC Public Health (2008) 0.87
Metabolic syndrome increases carotid artery stiffness: the Northern Manhattan Study. Int J Stroke (2010) 0.87
Metabolic syndrome with hyperglycemia and the risk of ischemic stroke. Yonsei Med J (2013) 0.86
Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ (2016) 0.86
Molecular determinants of the cardiometabolic phenotype. Endocr Metab Immune Disord Drug Targets (2010) 0.84
Prevalence of 10-year risk of cardiovascular diseases and associated risks in canadian adults: the contribution of cardiometabolic risk assessment introduction. Int J Hypertens (2013) 0.84
Prevalence of metabolic syndrome and pre-metabolic syndrome in health professionals: LATINMETS Brazil study. Diabetol Metab Syndr (2015) 0.84
Subclinical Myocardial Dysfunction in Metabolic Syndrome Patients without Hypertension. J Cardiovasc Ultrasound (2011) 0.83
Sex factors in the metabolic syndrome as a predictor of cardiovascular disease. Endocrinol Metab (Seoul) (2014) 0.83
Usefulness of combining serum uric acid and high-sensitivity C-reactive protein for risk stratification of patients with metabolic syndrome in community-dwelling women. Endocrine (2013) 0.83
Metabolic Syndrome versus Framingham Risk Score for Association of Self-Reported Coronary Heart Disease: The 2005 Korean Health and Nutrition Examination Survey. Diabetes Metab J (2012) 0.82
The clustering of cardiovascular disease risk factors and their impacts on annual medical expenditure in Japan: community-based cost analysis using Gamma regression models. BMJ Open (2013) 0.82
Linkage of epidemiologic evidence with the clinical aspects of metabolic syndrome. Korean Circ J (2012) 0.82
Risk of Coronary Heart Disease in Different Criterion of Impaired Fasting Glucose: A Meta-Analysis. Medicine (Baltimore) (2015) 0.82
Effects of alpha-tocopherol on oxidative status and metabolic profile in overweight women. Int J Environ Res Public Health (2007) 0.81
Impaired coronary microvascular endothelial function in men with metabolic syndrome. World J Cardiol (2010) 0.81
Gender differences in association between metabolic syndrome and carotid intima media thickness. J Diabetes Metab Disord (2012) 0.81
An Anthropometric Risk Index Based on Combining Height, Weight, Waist, and Hip Measurements. J Obes (2016) 0.81
Association between γ-glutamyl transferase and metabolic syndrome: a cross-sectional study of an adult population in Beijing. Int J Environ Res Public Health (2013) 0.80
The association between serum uric acid levels, metabolic syndrome and cardiovascular disease in middle aged and elderly Chinese: results from the DYSlipidemia International Study. BMC Cardiovasc Disord (2015) 0.80
Metabolic syndrome and the burden of cardiovascular disease in Caribbean Hispanic women living in northern Manhattan: a red flag for education. Metab Syndr Relat Disord (2009) 0.80
Metabolic syndrome in the Mediterranean region: Current status. Indian J Endocrinol Metab (2012) 0.80
Leptin:adiponectin ratio and metabolic syndrome in the general Japanese population. Korean J Lab Med (2011) 0.80
Daily sleep duration and risk of metabolic syndrome among middle-aged and older Chinese adults: cross-sectional evidence from the Dongfeng-Tongji cohort study. BMC Public Health (2015) 0.80
Inter-relationships between the severity of metabolic syndrome, insulin and adiponectin and their relationship to future type 2 diabetes and cardiovascular disease. Int J Obes (Lond) (2016) 0.80
Prevalence of Metabolic Syndrome and Its Components in the Iranian Adult Population: A Systematic Review and Meta-Analysis. Iran Red Crescent Med J (2015) 0.80
Influence of endothelial dysfunction on telomere length in subjects with metabolic syndrome: LIPGENE study. Age (Dordr) (2014) 0.80
Insulin Enhances Endothelial Function Throughout the Arterial Tree in Healthy But Not Metabolic Syndrome Subjects. J Clin Endocrinol Metab (2016) 0.80
Impaired myocardial blood flow reserve in subjects with metabolic syndrome analyzed using positron emission tomography and N-13 labeled ammonia. Eur J Nucl Med Mol Imaging (2009) 0.79
Impact of metabolic syndrome on mortality and morbidity after coronary artery bypass grafting surgery. Res Cardiovasc Med (2014) 0.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
Long-term mortality after gastric bypass surgery. N Engl J Med (2007) 10.75
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med (2004) 10.35
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA (2006) 9.27
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med (2012) 7.93
Plasma adiponectin levels and risk of myocardial infarction in men. JAMA (2004) 7.46
Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care (2008) 7.27
Calcium/vitamin D supplementation and cardiovascular events. Circulation (2007) 6.63
Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 6.51
T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation (2007) 6.23
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med (2015) 6.12
Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol (2010) 5.79
Comparison of the instructional efficacy of Internet-based CME with live interactive CME workshops: a randomized controlled trial. JAMA (2005) 5.50
Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med (2014) 5.47
Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes (2003) 5.43
Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol (2011) 5.30
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA (2003) 5.26
Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol (2008) 4.83
Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation (2011) 4.78
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet (2011) 4.67
Design and implementation of the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol (2010) 4.61
Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med (2004) 4.38
Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. Am J Epidemiol (2008) 4.28
An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med (2006) 4.23
A 52-week placebo-controlled trial of evolocumab in hyperlipidemia. N Engl J Med (2014) 4.14
Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care (2005) 3.96
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation (2004) 3.96
Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91
Chronic hyperglycemia and subclinical myocardial injury. J Am Coll Cardiol (2012) 3.91
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation (2005) 3.85
Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation (2011) 3.68
Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med (2011) 3.52
Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med (2012) 3.47
Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade. J Exp Med (2006) 3.38
Trends in prehospital delay time and use of emergency medical services for acute myocardial infarction: experience in 4 US communities from 1987-2000. Am Heart J (2005) 3.32
Correlates of repeat lipid testing in patients with coronary heart disease. JAMA Intern Med (2013) 3.30
Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet (2010) 3.24
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med (2002) 3.15
Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS study. Am J Respir Crit Care Med (2013) 3.09
Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med (2002) 3.04
The Next PAGE in understanding complex traits: design for the analysis of Population Architecture Using Genetics and Epidemiology (PAGE) Study. Am J Epidemiol (2011) 2.98
Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 2.97
Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria. Circ Heart Fail (2012) 2.88
Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med (2009) 2.85
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Whole-genome sequence-based analysis of high-density lipoprotein cholesterol. Nat Genet (2013) 2.62
GIS approaches for the estimation of residential-level ambient PM concentrations. Environ Health Perspect (2006) 2.53
Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol (2007) 2.53
Sugar-sweetened soda consumption, hyperuricemia, and kidney disease. Kidney Int (2009) 2.48
A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J (2007) 2.44
A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis. J Am Coll Cardiol (2005) 2.42
Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood (2002) 2.41
Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes (2004) 2.38
Accuracy of commercial geocoding: assessment and implications. Epidemiol Perspect Innov (2006) 2.38
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol (2011) 2.37
Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation (2005) 2.36
Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles. Blood (2008) 2.36
Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study. Stroke (2006) 2.33
Using the whole cohort in the analysis of case-cohort data. Am J Epidemiol (2009) 2.27
Association of higher levels of ambient criteria pollutants with impaired cardiac autonomic control: a population-based study. Am J Epidemiol (2004) 2.23
Accuracy and repeatability of commercial geocoding. Am J Epidemiol (2004) 2.21
Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. Am Heart J (2009) 2.21
Twenty-two-year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987-2008. Circulation (2012) 2.20
Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation (2009) 2.19
Racial differences in glycemic markers: a cross-sectional analysis of community-based data. Ann Intern Med (2011) 2.19
Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J (2006) 2.16
The metabolic syndrome and risk of incident colorectal cancer. Cancer (2006) 2.16
Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Hypertension (2003) 2.12
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Am J Cardiol (2005) 2.11
Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science (2008) 2.10
Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care (2007) 2.08
Generalization and dilution of association results from European GWAS in populations of non-European ancestry: the PAGE study. PLoS Biol (2013) 2.08
Relationship between periodontal disease and C-reactive protein among adults in the Atherosclerosis Risk in Communities study. Arch Intern Med (2003) 2.06
A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med (2007) 2.05
The effect of various intensities of physical activity and chronic inflammation in men and women by diabetes status in a national sample. Diabetes Res Clin Pract (2012) 2.04
A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer. Mayo Clin Proc (2002) 2.04
Cross-sectional associations of oral health measures with cognitive function in late middle-aged adults: a community-based study. J Am Dent Assoc (2013) 2.04
Evaluation and comparison of food records, recalls, and frequencies for energy and protein assessment by using recovery biomarkers. Am J Epidemiol (2011) 2.04